R37L (p.Arg37Leu) variant of KRT5 (Keratin, type II cytoskeletal 5)

R37L (p.Arg37Leu) in KRT5 (Keratin, type II cytoskeletal 5) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

R37L (p.Arg37Leu) variant details